Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

At AESGP, Challenges Temper Optimism As Leaders View Future Of OTC

This article was originally published in The Tan Sheet

Executive Summary

At the 45th annual meeting of the Association of the European Self-Medication Industry, executives reflected on the challenges of the European market even as OTC business units enjoy increased prominence within global and diversified organizations

You may also be interested in...



In Europe, Centralized OTC Switch Still Has A Few Bugs

The European Union's diversity means that when it comes to the new centralized procedure for Rx-to-OTC switches, there are several details yet to be ironed out, according to OTC industry executives

Nycomed Prepares To Launch First Nonprescription PPI With EU-Wide Approval

Nycomed is gearing up to launchPantozol Control (pantoprazole 20 mg) later this year when the firm expects an approval for European Union nonprescription marketing authorization

Pfizer To House Consumer, Nutritional Divisions In Diversified Businesses Unit

Pfizer will appoint Wyeth's consumer health president to manage its new Diversified Businesses group, which will include consumer, nutritional and animal health, as part of a reorganization following the companies' planned merger

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS103005

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel